<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">abd</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27579747</article-id>
      <article-id pub-id-type="pmc">4999110</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20164104</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Rheumatoid arthritis and pseudo-vesicular skin plaques: rheumatoid
neutrophilic dermatosis<xref ref-type="fn" rid="fn1">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Manriquez</surname>
            <given-names>Juan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Giesen</surname>
            <given-names>Laura</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>del Puerto</surname>
            <given-names>Constanza</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gonzalez</surname>
            <given-names>Sergio</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <aff id="aff1"><label>1</label>Pontificia Universidad Catolica de Chile - Santiago,
Chile.</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1">Mailing address: Juan Manriquez, Department of Dermatology,
Pontificia Universidad Catolica de Chile, Marcoleta 350. Santiago - Chile.
E-mail: <email>jjmanriq@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Jul-Aug</season>
        <year>2016</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jul-Aug</season>
        <year>2016</year>
      </pub-date>
      <volume>91</volume>
      <issue>4</issue>
      <fpage>500</fpage>
      <lpage>502</lpage>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>10</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>12</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2016 by Anais Brasileiros de
Dermatologia</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>A 54 year-old woman with a 3-year history of rheumatoid arthritis (RA) consulted
us because of weight loss, fever and skin eruption. On physical examination,
erythematous plaques with a pseudo-vesicular appearance were seen on the back of
both shoulders. Histological examination was consistent with rheumatoid
neutrophilic dermatosis (RND). After 3 days of prednisone treatment, the skin
eruption resolved. RND is a rare cutaneous manifestation of seropositive RA,
characterized by asymptomatic, symmetrical erythematous plaques with a
pseudo-vesicular appearance. Histology characteristically reveals a dense,
neutrophilic infiltrate with leucocitoclasis but without other signs of
vasculitis. Lesions may resolve spontaneously or with RA treatment. This case
illustrates an uncommon skin manifestation of active rheumatoid arthritis.</p>
      </abstract>
      <kwd-group>
        <kwd>Arthritis</kwd>
        <kwd>Arthritis, rheumatoid</kwd>
        <kwd>Rheumatoid factor</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Rheumatoid arthritis (RA) is an autoimmune, chronic, systemic disease that affects 1%
of the Western population, particularly women, during the fifth decade of
life.<sup><xref rid="r1" ref-type="bibr">1</xref></sup> Clinically, it
presents as a chronic, symmetric and destructive polyarthritis. Extra-articular
manifestations of RA (ExRA) implicate a severe and active disease, and are
associated with increased morbidity and premature mortality+.<sup><xref rid="r2" ref-type="bibr">2</xref></sup> It is believed that the same
cytokines involved in the synovial pathology are responsible for ExRA, producing
damage in multiple systems: musculoskeletal regions, skin, eye, lungs, heart,
kidneys, salivary glands, blood vessels, central nervous system and bone marrow.</p>
      <p>We describe a patient with severe and active RA who presented pseudo-vesicular skin
eruption on her shoulders.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 54 year-old female with a 3-year history of RA consulted us because of an
asymptomatic, pseudo-vesicular skin eruption. She had not been on any treatment over
the preceding 3 years, and was hospitalized because of a six-month history of weight
loss, morning stiffness in her hands, fever and generalized arthralgia. On physical
examination, the patient presented two symmetrically-distributed, erythematous
plaques with a pseudo-vesicular appearance on the back of both shoulders (<xref ref-type="fig" rid="f1">Figure 1</xref>). Laboratory exams revealed: microcytic
anemia (hemoglobin: 10.1g/dl with MCV of 79.8fl), normal reticulocyte count;
leucopenia (3,300 cells/uL) with normal neutrophil count; lymphopenia (729
cells/ul), high sedimentation rate (120mm/hr); hypoalbuminemia (2.9g/dl); and
positive rheumatoid factor. A skin biopsy showed epidermal parakeratosis, irregular
acanthosis, spongiosis with intraepidermal spongiotic blistering, and focal
lymphocytes exocytosis. An accentuated papillary edema was noted on the upper
dermis, followed by: an intense, predominately neutrophilic infiltration with
necrosis in the deep reticular dermis; some vessels with a neutrophilic
infiltration; as well as leucocitoclasis, but without any other signs of vasculitis
(<xref ref-type="fig" rid="f2">Figure 2</xref>). Histological findings were
consistent with a diffuse, neutrophilic dermatosis, suggesting rheumatoid
neutrophilic dermatosis.</p>
      <p>
        <fig id="f1" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <p><bold>(a)</bold> Slightly erythematous plaques symmetrically located on
the back of both shoulders. <bold>(b)</bold> Upon closer observation,
the skin over the lesions was remarkable because of its pseudo-vesicular
appearance</p>
          </caption>
          <graphic xlink:href="abd-91-04-0500-g01"/>
        </fig>
      </p>
      <p>
        <fig id="f2" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <p><bold>(a-b</bold>, Haematoxylin-eosin, X40 and X100, respectively.)
Intense spongiosis and spongiotic microvesicles in the epidermis, with
dense and diffuse infiltration of neutrophils at the dermis. No
microorganisms were identified</p>
          </caption>
          <graphic xlink:href="abd-91-04-0500-g02"/>
        </fig>
      </p>
      <p>Because of active and severe RA, a course of 60mg/d of prednisone was initiated, with
rapid regression of skin eruption after the third day of therapy.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>It is estimated that 40% of RA patients will develop an extra-articular
manifestation.<sup><xref rid="r3" ref-type="bibr">3</xref></sup> Risk
factors for ExRA include older age, presence of rheumatoid factor and/or antinuclear
antibodies, early disability and smoking.<sup><xref rid="r4" ref-type="bibr">4</xref></sup></p>
      <p>Skin manifestations are the most frequent ExRA manifestations, the most common of
which are rheumatoid nodules.<sup><xref rid="r5" ref-type="bibr">5</xref></sup>
Other cutaneous ExRA include: skin ulcers, Raynaud phenomenon, vasculitis and
pyoderma gangrenosum. Less frequent ExRA manifestations include palisading
granulomatous dermatitis, neutrophilic lobular paniculitis, and neutrophilic
dermatoses such as Sweet syndrome and rheumatoid neutrophilic dermatosis.<sup><xref rid="r6" ref-type="bibr">6</xref></sup></p>
      <p>Rheumatoid neutrophilic dermatosis (RND) was first described by Ackerman in
1978.<sup><xref rid="r7" ref-type="bibr">7</xref></sup> The clinical
manifestations of RND include erythematous to yellow-colored papules, plaques or
nodules, with an urticariform appearance. On rarer occasions, annular, ulcerative,
crusted lesions may be seen, or sometimes lesions with a pseudo-vesicular surface,
as in this case.<sup><xref rid="r6" ref-type="bibr">6</xref></sup> Lesions are
symmetrically distributed above the joints, extensor surfaces of the extremities, or
the trunk. <sup><xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r8" ref-type="bibr">8</xref></sup></p>
      <p>Histologically, RND is characterized by papillary edema and a dense, neutrophilic
infiltrate, which may extend into the subcutaneous fat, with some leukocytoclasis in
the deep dermis. <sup><xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref></sup> The infiltrate may be admixed with eosinophils,
lymphocytes and hystiocytes. Epidermal changes in RND are less prominent but, due to
the dermal edema, intraepidermal blistering may be seen, as in the case here
described, which correlates clinically with the pseuso-vesicular surface of the
lesions.<sup><xref rid="r9" ref-type="bibr">9</xref></sup></p>
      <p>The main differential diagnoses of RND include: Sweet syndrome - which may be
identical to RND clinically and histologically-, erythema elevatum diutinium,
neutrophilic urticaria, urticarial vasculitis, pyoderma gangrenosum,
bowel-associated dermatosis-arthritis syndrome and Beh&#xE7;et's
disease.<sup><xref rid="r6" ref-type="bibr">6</xref></sup> Since RND and
Sweet syndrome can be identical, RND may be regarded as Sweet syndrome in patients
with active seropositive RA.</p>
      <p>Lesions tend to resolve spontaneously or with improvement in the RA, as in this case.
However, recurrence is common with exacerbation of RA. Lesions usually heal with no
scarring.<sup><xref rid="r6" ref-type="bibr">6</xref></sup> Therefore, the
first line treatment is RA therapy with systemic corticosteroids. Furthermore,
anti-neutrophilic therapies - such as dapsone or colchicine- may lead to rapid
resolution of RND.<sup><xref rid="r6" ref-type="bibr">6</xref></sup></p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="other" id="fn1">
        <label>*</label>
        <p>Work performed at the Pontificia Universidad Catolica de Chile - Santiago,
Chile.</p>
      </fn>
      <fn fn-type="supported-by">
        <p>Financial Support: None.</p>
      </fn>
      <fn fn-type="COI-statement">
        <p>Conflict of Interest: None.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scott</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Wolfe</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Huizinga</surname>
              <given-names>TW</given-names>
            </name>
          </person-group>
          <article-title>Rheumatoid arthritis</article-title>
          <source>Lancet</source>
          <year>2010</year>
          <volume>376</volume>
          <fpage>1094</fpage>
          <lpage>1108</lpage>
          <pub-id pub-id-type="pmid">20870100</pub-id>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turesson</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>O'Fallon</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Crowson</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Gabriel</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Matteson</surname>
              <given-names>EL</given-names>
            </name>
          </person-group>
          <article-title>Occurrence of extraarticular disease manifestations is associated
with excesso mortality in a community based cohort of patients with
rheumatoid arthritis</article-title>
          <source>J Rheumatol</source>
          <year>2002</year>
          <volume>29</volume>
          <fpage>62</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="pmid">11824973</pub-id>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Myasoedova</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Crowson</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Turesson</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gabriel</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Matteson</surname>
              <given-names>EL</given-names>
            </name>
          </person-group>
          <article-title>Incidence of extraarticular rheumatoid arthritis in Olmsted
County, Minnesota, in 1995-2007 versus 1985-1994: a population-based
study</article-title>
          <source>J Rheumatol</source>
          <year>2011</year>
          <volume>38</volume>
          <fpage>983</fpage>
          <lpage>989</lpage>
          <pub-id pub-id-type="pmid">21459933</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turesson</surname>
              <given-names>C1</given-names>
            </name>
            <name>
              <surname>Schaid</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Weyand</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Jacobsson</surname>
              <given-names>LT</given-names>
            </name>
            <name>
              <surname>Goronzy</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Petersson</surname>
              <given-names>IF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Association of HLA-C3 and smoking with vasculitis in patients
with rheumatoid arthritis</article-title>
          <source>Arthritis Rheum</source>
          <year>2006</year>
          <volume>54</volume>
          <fpage>2776</fpage>
          <lpage>2783</lpage>
          <pub-id pub-id-type="pmid">16947780</pub-id>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sayah</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>English 3rd</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Rheumatoid arthritis: a review of the cutaneous
manifestations</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2005</year>
          <volume>53</volume>
          <fpage>191</fpage>
          <lpage>209</lpage>
          <pub-id pub-id-type="pmid">16021111</pub-id>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lazarov</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mor</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cordoba</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mekori</surname>
              <given-names>YA</given-names>
            </name>
          </person-group>
          <article-title>Rheumatoid neutrophilic dermatitis: an initial dermatological
manifestation of seronegative rheumatoid arthritis</article-title>
          <source>J Eur Acad Dermatol Venereol</source>
          <year>2002</year>
          <volume>16</volume>
          <fpage>74</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="pmid">11952297</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Ackerman</surname>
              <given-names>AB</given-names>
            </name>
          </person-group>
          <source>Histopathologic Diagnosis of Inflammatory Skin Diseases: A Method by
Pattern Analysis</source>
          <year>1978</year>
          <publisher-loc>Philadelphia</publisher-loc>
          <publisher-name>Lea &amp; Febiger</publisher-name>
          <fpage>449</fpage>
          <lpage>451</lpage>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamamoto</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous manifestations associated with rheumatoid
arthritis</article-title>
          <source>Rheumatol Int</source>
          <year>2009</year>
          <volume>29</volume>
          <fpage>979</fpage>
          <lpage>988</lpage>
          <pub-id pub-id-type="pmid">19242695</pub-id>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lowe</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kornfeld</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Clayman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Golitz</surname>
              <given-names>LE</given-names>
            </name>
          </person-group>
          <article-title>Rheumatoid neutrophilic dermatitis</article-title>
          <source>J Cutan Pathol</source>
          <year>1992</year>
          <volume>19</volume>
          <fpage>48</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="pmid">1556266</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mashek</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Pham</surname>
              <given-names>CT</given-names>
            </name>
            <name>
              <surname>Helm</surname>
              <given-names>TN</given-names>
            </name>
            <name>
              <surname>Klaus</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Rheumatoid neutrophilic dermatitis</article-title>
          <source>Arch Dermatol</source>
          <year>1997</year>
          <volume>133</volume>
          <fpage>757</fpage>
          <lpage>760</lpage>
          <pub-id pub-id-type="pmid">9197831</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
